Press Releases - 2022-12-07
PureTech Founded Entity Vor Bio Announces First AML Patient Successfully Transplanted with its Investigational Trem-cel (VOR33) and Tolerated Mylotarg™
Press Releases - 2022-11-30
Wholly Owned Pipeline
Wholly Owned Pipeline - LYT-310
PureTech Announces New Therapeutic Candidate, LYT-310, an Oral Form of Cannabidiol (CBD) Leveraging PureTech's Glyph™ Platform
Press Releases - 2022-09-05
Wholly Owned Pipeline
Wholly Owned Pipeline - LYT-100
PureTech Presents Data for LYT-100 (Deupirfenidone) Supporting Design of Dose-Ranging Trial in Idiopathic Pulmonary Fibrosis (IPF) at European Respiratory Society International Congress 2022